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We are fortunate to have invited commentaries from the laboratories of Dr Cathy Lord and Dr Fred Volkmar
offering their perspectives on the new Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria for the
autism spectrum. Both commentaries note how DSM-5 collapses the earlier diagnostic categories of the pervasive
developmental disorders into a single category of autism spectrum disorder. In addition, DSM-5 collapses social and
communication domains into a single combined domain. The commentaries go on to discuss the positive aspects
of these changes and raise some areas of potential concern. We support the evidence-based changes to autism
diagnosis found in DSM-5, and look forward to further studies on the autism phenotype as this has implications for
diagnosis and treatment. As our mechanistic understanding of autism improves, diagnoses based on behavioral
parameters will continue to provide opportunities for interventions targeting the behaviors, while etiological
diagnoses will provide opportunities for interventions tailored to etiology.We are fortunate to have invited commentaries from the
laboratories of Dr Cathy Lord and Dr Fred Volkmar of-
fering their perspectives on the new Diagnostic and Stat-
istical Manual of Mental Disorders (DSM)-5 criteria for
the autism spectrum.
Both Lord and Volkmar are world-leaders in autism
and in the autism phenotype, and both have been very
involved in the DSM: Volkmar was the primary author
of the DSM-IV autism and pervasive developmental dis-
orders section, and Lord has been equally active in the
Neurodevelopmental Disorders Workgroup of DSM-5.
As such, there are none more qualified to comment on
what has been potentially gained or lost in the transition
from the fourth edition to the fifth edition of this bible
of psychiatric classification and diagnosis.
DSM-5 presents an interesting new approach to the
diagnosis of the autism spectrum. On the one hand, as
both commentaries highlight, DSM-5 collapses the show
$132#?>earlier diagnostic categories of pervasive devel-
opmental disorders into a single category, termed autism
spectrum disorder (ASD), and further collapses the com-
munication and social domains into a single social-
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tal disorders that is likely to be distinct and map to
unique and identifiable etiology factors (i.e., Rett syn-
drome) has been moved out of the ASD category. Over-
all, these changes have the effect of a greater focus on
the behavioral manifestations of ASD, encompassing
both domains and severity, and a move away from etio-
logical considerations.
The commentary by Lord’s group is broadly positive
about DSM-5 for three reasons: DSM-5 has merged five
subgroups with low inter-rater reliability into a single
group with high inter-rater reliability; DSM-5 has re-
duced the autistic spectrum from three factors down to
two, in recognition that social and communication skills
are inextricably intertwined; and DSM-5 has introduced
a severity scale in recognition of the diversity of the
spectrum.
The commentary by Volkmar’s group raises some con-
cern about DSM-5 for three reasons: DSM-5 will make it
difficult for ongoing longitudinal research studies to com-
pare like with like; there is some evidence (reviewed by
them) that some high-functioning individuals will no lon-
ger meet diagnostic criteria for ASD, and will thereby be-
come ineligible for services and treatment; and the
removal of the subgroup of Asperger syndrome is too ex-
treme a move, when its reliability could have been im-
proved by some tweaking, retaining its clinical value,
rather than by deleting it entirely. What impact remov-
ing Asperger syndrome from DSM-5 will have onioMed Central Ltd. This is an Open Access article distributed under the terms of
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mains to be seen.
The Volkmar commentary goes on to argue that we
do not know what the broader impact of the DSM-5
changes will be. If DSM-5 does lead to a percentage of
people on the autism spectrum no longer meeting cri-
teria for a diagnosis and thereby losing services, this
is very serious indeed. We know that many high-
functioning individuals with superficially very good
social skills may nevertheless struggle psychologically –
that outward behavior can mask inner suffering – and
that comorbid depression is common in this group.
Without appropriate services, such individuals may ac-
quire even greater risk of secondary depression, with all
that this implies in relation to suicidality risk. It will be
important for future clinical research to monitor the im-
pact of DSM-5 carefully, to see whether these fears are
well-founded or unfounded.
More subtle changes in DSM-5 include the inclusion
of stereotyped language into the repetitive and restrictive
behaviors domain, and the addition of sensory issues
into the definition. The former change is supported by
empirical data. The latter change is more exploratory,
recognizing that sensory over-responsivity or under-
responsivity is frequently reported in ASD. It will be in-
teresting to see how sensory processing disorders unfold
when clinicians and researchers adopt standard instru-
ments to report such sensory processing changes in ASD.
Other changes in DSM-5 may impact the diagnosis of
ASD. Most importantly, the addition of a new category
of social-communication disorder may lead to diagnostic
changes that are not currently predictable. This latter
point is perhaps the one that has caused the greatest dis-
cussion. We simply cannot predict how changing diag-
nostic criteria impact the real world. The DSM-5
committees are to be commended for the work in trying
to assess impact, but there are far too many factors and
affected parties to be able to make sanguine predictions.
For example, a township or insurance company seeking
to reduce its financial obligation could perhaps use
changing diagnostic criteria to argue that certain individ-
uals no longer qualify for specific services. If this occurs,
for the families in question the impact will be profound,
and the ensuing delays in services very worrying.
In an ideal world, where appropriate and feasible, be-
havioral diagnosis of ASD would be coupled with an
etiological diagnosis. Such a dual approach would then
leverage evidence-based treatment (whether pharmaco-
logical or psychological) that takes advantage of inter-
ventions tailored to the individual behavioral expression
and etiology. For example, in a child with Rett syndrome,
ASD deficits might be addressed through behavioral inter-
ventions, while neurobiological alterations that underlie
the behavioral changes might be addressed by noveltherapeutics developed to target specific changes caused
by the loss of a functional copy of theMECP2 gene. A par-
allel phenotype/etiology approach could be applied to
other high-risk mutations in ASD, such as mutations in
FMR1, MBD5, SHANK3, TSC1 or TSC2, and UBE3A,
copy number variation at 15q11-13, 16p11, 22q11, and
22q13, and smaller or larger chromosomal disorders.
We thank the Lord and Volkmar groups for contributing
to this important debate, and look forward to publishing
more research evaluating these diagnostic changes. The de-
cision to include these commentaries also reflects the edi-
torial vision of Molecular Autism, which is to understand
autism at multiple levels, whether molecular, neural, cogni-
tive or behavioral. To reflect this vision, Molecular Autism
now has a strapline: Brain, Cognition, and Behavior. We
encourage submissions of articles for publication reporting
high-quality autism research at all of these levels.
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